Massachusetts General Hospital

BiographySherri-Ann M. Burnett-Bowie is an endocrinologist and clinical researcher in the Bone and Mineral Metabolism Unit at Massachusetts General Hospital. She sees patients with bone and mineral disorders, as well as general endocrine disorders.

ResearchHer research is focused on defining the physiology of a new phosphate-regulating hormone, FGF23, and clinical trials of treatments for osteoporosis.

Publications

1. Burnett, S.M., S. Gunawardene, F.R. Bringhurst, H. Jueppner, H. Lee and J.S. Finkelstein. Regulation of c-terminal and intact FGF23 by dietary phosphate in men and women. J Bone Min Res: 21, 1187-1196, 2006. PMID: 16869716
2. Finkelstein, J.S., B.Z. Leder, S.M. Burnett, J.J. Wyland, H. Lee. A.V. de la Paz, K. Gibson and R.M. Neer. Effects of parathyroid hormone, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab: 91, 2882-2887, 2006. PMID: 16684825
3. Burnett-Bowie, S.M., K. Saag, A. Sebba, A.E. de Papp, E. Chen, E. Rosenberg, and S.L. Greenspan. Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates. J Clin Endocrinol Metab: 94, 1097-103, 2009. PMID: 19141590
4. Burnett-Bowie, S.M., M.P. Henao, M.E. Dere, H. Lee, B.Z. Leder. Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D and FGF23 levels in healthy men. J Bone Min Res: 24, 1681-5, 2009. PMCID: PMC2743281
5. Burnett-Bowie, S.M., E.A. McKay, H. Lee, B.Z. Leder. Effects of aromatase inhibition on bone mineral density and bone turnover in hypogonadal older men. J Clin Endocrinol Metab: 94, 4785-93, 2009. PMCID: PMC2795655
6. Bhan, I, S.M. Burnett-Bowie, J. Ye, M. Tonelli, R. Thadhani. Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol: 5, 460-7, 2010. PMCID: PMC2827576

In General awards and recognitions: May 4, 2012

In General awards and recognitions: May 4, 2012